MX2017009336A - Polinucleótidos dirigidos al sistema nervioso central. - Google Patents

Polinucleótidos dirigidos al sistema nervioso central.

Info

Publication number
MX2017009336A
MX2017009336A MX2017009336A MX2017009336A MX2017009336A MX 2017009336 A MX2017009336 A MX 2017009336A MX 2017009336 A MX2017009336 A MX 2017009336A MX 2017009336 A MX2017009336 A MX 2017009336A MX 2017009336 A MX2017009336 A MX 2017009336A
Authority
MX
Mexico
Prior art keywords
nervous system
central nervous
targeting polynucleotides
system targeting
polynucleotides
Prior art date
Application number
MX2017009336A
Other languages
English (en)
Inventor
Philip KELLS Adrian
Zhou Pengcheng
Hou Jinzhao
Wen-Yee Sah Dinah
Goulet Martin
RAMAMOORTHI Kartik
Shu Yanqun
Robert Stewart Gregory
Original Assignee
Voyager Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Voyager Therapeutics Inc filed Critical Voyager Therapeutics Inc
Publication of MX2017009336A publication Critical patent/MX2017009336A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se relaciona con composiciones y métodos para la preparación, fabricación y uso terapéutico de polinucleótidos que codifican cargas para el tratamiento de trastornos del SNC.
MX2017009336A 2015-01-16 2016-01-15 Polinucleótidos dirigidos al sistema nervioso central. MX2017009336A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562104101P 2015-01-16 2015-01-16
US201562152283P 2015-04-24 2015-04-24
US201562152185P 2015-04-24 2015-04-24
US201562159882P 2015-05-11 2015-05-11
US201562159888P 2015-05-11 2015-05-11
PCT/US2016/013671 WO2016115503A1 (en) 2015-01-16 2016-01-15 Central nervous system targeting polynucleotides

Publications (1)

Publication Number Publication Date
MX2017009336A true MX2017009336A (es) 2017-11-15

Family

ID=56406481

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017009336A MX2017009336A (es) 2015-01-16 2016-01-15 Polinucleótidos dirigidos al sistema nervioso central.
MX2022003323A MX2022003323A (es) 2015-01-16 2017-07-17 Polinucleotidos dirigidos al sistema nervioso central.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022003323A MX2022003323A (es) 2015-01-16 2017-07-17 Polinucleotidos dirigidos al sistema nervioso central.

Country Status (7)

Country Link
US (2) US20180021364A1 (es)
EP (2) EP3245221A4 (es)
AU (2) AU2016206478A1 (es)
CA (1) CA2970730A1 (es)
HK (1) HK1246815A1 (es)
MX (2) MX2017009336A (es)
WO (1) WO2016115503A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112410338A (zh) 2014-11-14 2021-02-26 沃雅戈治疗公司 调节性多核苷酸
US10597660B2 (en) 2014-11-14 2020-03-24 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
EP3286321A4 (en) * 2015-04-24 2018-10-17 University of Florida Research Foundation, Inc. Aav vector for treatment of friedreich's ataxia
CA3002406A1 (en) * 2015-10-29 2017-05-04 Voyager Therapeutics, Inc. Delivery of central nervous system targeting polynucleotides
HRP20231451T1 (hr) * 2016-02-05 2024-03-01 Emory University Ubrizgavanje jednolančanog ili samo-komplementarnog adeno-povezanog virusa 9 u cerebrospinalnu tekućinu
KR20240056729A (ko) 2016-05-18 2024-04-30 보이저 테라퓨틱스, 인크. 조절성 폴리뉴클레오티드
SG11201809643UA (en) 2016-05-18 2018-12-28 Voyager Therapeutics Inc Compositions and methods of treating huntington's disease
CA3042706A1 (en) * 2016-11-09 2018-05-17 Intrexon Corporation Frataxin expression constructs
WO2018204786A1 (en) 2017-05-05 2018-11-08 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (als)
CA3061368A1 (en) 2017-05-05 2018-11-08 Voyager Therapeutics, Inc. Compositions and methods of treating huntington's disease
CA3071978A1 (en) 2017-08-03 2019-02-07 Voyager Therapeutics, Inc. Compositions and methods for delivery of aav
WO2019060649A1 (en) * 2017-09-22 2019-03-28 Voyager Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
EP3687582A4 (en) * 2017-09-29 2021-07-14 Voyager Therapeutics, Inc. RESCUE OF CENTRAL AND PERIPHERAL NEUROLOGICAL PHENOTYPE OF FRIEDREICH ATAXIA BY INTRAVENOUS ADMINISTRATION
EP3697908A1 (en) 2017-10-16 2020-08-26 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis (als)
WO2019079240A1 (en) 2017-10-16 2019-04-25 Voyager Therapeutics, Inc. TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
US20210189423A1 (en) * 2017-10-17 2021-06-24 Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol Vectors for the treatment of friedreich's ataxia
EP3774854A1 (en) 2018-04-03 2021-02-17 Stridebio, Inc. Antibody-evading virus vectors
CN113383010A (zh) * 2018-09-28 2021-09-10 沃雅戈治疗公司 具有经工程化改造的启动子的共济蛋白表达构建体及其使用方法
CN113302201A (zh) * 2018-11-21 2021-08-24 斯特里迪比奥公司 重组病毒载体和用于产生所述重组病毒载体的核酸
EA202192501A1 (ru) 2019-03-21 2021-12-16 Страйдбайо, Инк. Рекомбинантные аденоассоциированные вирусные векторы
WO2020223236A1 (en) * 2019-04-29 2020-11-05 The Trustees Of The University Of Pennsylvania Novel aav capsids and compositions containing same
CN114502575A (zh) * 2019-06-10 2022-05-13 同源药物公司 用于arsa基因转移的腺相关病毒组合物和其使用方法
US20220211737A1 (en) * 2019-09-13 2022-07-07 Lacerta Therapeutics, Inc. Compositions and methods for treatment of friedreichs ataxia
GB201913974D0 (en) * 2019-09-27 2019-11-13 King S College London Vector
WO2021076925A1 (en) 2019-10-17 2021-04-22 Stridebio, Inc. Adeno-associated viral vectors for treatment of niemann-pick disease type c
WO2021127533A1 (en) * 2019-12-19 2021-06-24 The Trustees Of The University Of Pennsylvania Compositions for treating friedreich's ataxia
BR112023001648A2 (pt) 2020-07-27 2023-04-04 Anjarium Biosciences Ag Moléculas de dna de fita dupla, veículo de entrega e método para preparar uma molécula de dna com extremidade em grampo
CN118043039A (zh) 2021-10-25 2024-05-14 诺华股份有限公司 用于改善腺相关病毒（aav）递送的方法

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US5741657A (en) 1995-03-20 1998-04-21 The Regents Of The University Of California Fluorogenic substrates for β-lactamase and methods of use
US7931642B2 (en) 1998-09-18 2011-04-26 Codman Neuro Sciences Sarl Infusion pump comprising a computer for calculating the respective maximum permissible dosage
US6755814B2 (en) 1999-05-26 2004-06-29 Codman Neuro Sciences Sarl Implantable infusion pump with level measurement
US7366561B2 (en) 2000-04-07 2008-04-29 Medtronic, Inc. Robotic trajectory guide
JP2004514407A (ja) 2000-04-28 2004-05-20 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 異種キャプシド中にシュードタイピングされたａａｖ５キャプシドおよびａａｖ５ベクターを含む組換えａａｖベクター
US6549803B1 (en) 2000-05-08 2003-04-15 Image-Guided Neurologics Inc. Method and apparatus for targeting material delivery to tissue
US6464662B1 (en) 2000-07-26 2002-10-15 Image-Guided Neurologics, Inc. Drug delivery and catheter systems, apparatus and processes
US6572579B1 (en) 2000-09-13 2003-06-03 Image-Guided Neurologics, Inc. Drug delivery and catheter systems, apparatus and processes
AU2002347035B2 (en) 2001-09-28 2008-04-03 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V Micro-RNA molecules
CA2406745C (en) 2001-11-13 2006-01-10 The Trustees Of The University Of Pennsylvania A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
FI3517134T3 (fi) 2001-12-17 2024-04-03 Univ Pennsylvania Adeno-assosioituneen viruksen (aav) serotyypin 8 sekvenssejä, niitä sisältäviä vektoreita ja niiden käyttöjä
EP3339430A1 (en) 2001-12-17 2018-06-27 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses thereof
US7715902B2 (en) 2002-09-12 2010-05-11 Brainlab Ag Determining distribution for planning an infusion
US6691948B1 (en) 2003-04-10 2004-02-17 The United States Of America As Represented By The Secretary Of The Navy High torque rocket nozzle
US7683036B2 (en) 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
US7848543B2 (en) 2004-02-05 2010-12-07 Brainlab Ag Method and system for prediction and management of material and information transport in an organism
US7637897B2 (en) 2004-10-25 2009-12-29 Codman Neuro Sciences Sarl Implantable pump with integrated refill detection
EP1768041B1 (en) 2005-09-22 2016-04-13 Brainlab AG Brain tissue classification
US9101282B2 (en) 2005-09-22 2015-08-11 Brainlab Ag Brain tissue classification
US8141844B2 (en) 2005-10-26 2012-03-27 Codman NeuroSciences Sàrl Flow rate accuracy of a fluidic delivery system
US8240635B2 (en) 2005-10-26 2012-08-14 Codman Neuro Sciences Sárl Flow rate accuracy of a fluidic delivery system
US7905878B2 (en) 2005-10-31 2011-03-15 Codman & Shurtleff, Inc. Implantable pump with reservoir level detector
EP1788498A1 (en) 2005-11-21 2007-05-23 BrainLAB AG Apparatus for infusing substances
WO2007064739A2 (en) 2005-11-29 2007-06-07 Surgi-Vision, Inc. Mri-guided localization and/or lead placement systems, related methods, devices and computer program products
EP2007795B1 (en) 2006-03-30 2016-11-16 The Board Of Trustees Of The Leland Stanford Junior University Aav capsid proteins
US7725272B2 (en) 2006-03-30 2010-05-25 Codman Neuro Sciences, Sarl Methods and devices for monitoring fluid of an implantable infusion pump
US20100030102A1 (en) 2006-05-15 2010-02-04 David Poston Active Delivery and Flow Redirections: Novel Devices and Method of Delivery of Materials to Patients
US7998128B2 (en) 2006-05-15 2011-08-16 Therataxis, LLC. Active delivery and flow redirection: novel devices and method of delivery of materials to patients
EP1992957B1 (en) 2007-05-16 2013-01-02 BrainLAB AG Method for estimating the physiological parameters defining the edema induced upon infusion of fluid from an intraparenchymally placed catheter
ES2557482T3 (es) 2007-05-17 2016-01-26 Medgenesis Therapeutix Inc. Catéter de entrega mejorada por convección con un miembro de rigidización eliminable
WO2008144232A2 (en) 2007-05-18 2008-11-27 The Johns Hopkins University A treatment simulator for brain diseases and method of use thereof
US8175677B2 (en) 2007-06-07 2012-05-08 MRI Interventions, Inc. MRI-guided medical interventional systems and methods
EP2176283B1 (en) 2007-07-14 2016-11-02 University of Iowa Research Foundation Methods and compositions for treating brain diseases
US8548569B2 (en) 2007-09-24 2013-10-01 MRI Interventions, Inc. Head fixation assemblies for medical procedures
US8099150B2 (en) 2007-09-24 2012-01-17 MRI Interventions, Inc. MRI-compatible head fixation frame with cooperating head coil apparatus
CA2700523A1 (en) 2007-09-24 2009-04-02 Surgivision, Inc. Mri-guided medical interventional systems and methods
WO2009067205A1 (en) 2007-11-21 2009-05-28 Surgi-Vision, Inc. Methods, systems and computer program products for positioning a guidance apparatus relative to a patient
US8545405B2 (en) 2008-04-23 2013-10-01 Therataxis, Llc Device, methods, and control for sonic guidance of molecules and other material utilizing time-reversal acoustics
US8083720B2 (en) 2008-05-13 2011-12-27 Solar Matthew S Device and method for delivering therapeutic agents to an area of the body
AR076634A1 (es) 2008-11-21 2011-06-29 Medgenesis Therapeutix Inc Composiciones y metodo para tratar desordenes del sistema nervioso central
WO2010096495A1 (en) 2009-02-18 2010-08-26 The Regents Of The University Of California Device, methods, and control for sonic guidance of molecules and other material utilizing time-reversal acoustics
WO2010138263A2 (en) * 2009-05-28 2010-12-02 University Of Massachusetts Novel aav 's and uses thereof
WO2012116265A2 (en) 2011-02-24 2012-08-30 MRI Interventions, Inc. Mri-guided catheters
US8396532B2 (en) 2009-06-16 2013-03-12 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US8679479B2 (en) 2009-06-29 2014-03-25 Aerase, Inc. Methods for purifying pegylated arginase
US8231563B2 (en) 2009-12-30 2012-07-31 Codman Neuro Sciences Sarl Electrokinetic actuator to titrate fluid flow
US10105485B2 (en) 2010-04-16 2018-10-23 MRI Interventions, Inc. MRI surgical systems including MRI-compatible surgical cannulae for transferring a substance to and/or from a patient
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
PL2598525T3 (pl) * 2010-07-28 2016-03-31 Roberto Testi Mutanty frataksyny
WO2012018881A2 (en) 2010-08-03 2012-02-09 Alnylam Pharmaceuticals, Inc. Methods and compositions for the regulation of rna
JP5704361B2 (ja) 2010-10-27 2015-04-22 学校法人自治医科大学 神経系細胞への遺伝子導入のためのアデノ随伴ウイルスビリオン
US9044492B2 (en) * 2011-02-04 2015-06-02 Cellectis Sa Method for modulating the efficiency of double-strand break-induced mutagenesis
EP2500434A1 (en) 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
WO2013019830A2 (en) 2011-08-01 2013-02-07 Alcyone Lifesciences, Inc. Microfluidic drug delivery devices
US9192393B2 (en) 2012-05-31 2015-11-24 MRI Interventions, Inc. MRI compatible surgical drills and related methods
US10206693B2 (en) 2012-07-19 2019-02-19 MRI Interventions, Inc. MRI-guided medical interventional systems and methods
US9498290B2 (en) 2012-07-19 2016-11-22 MRI Interventions, Inc. Surgical navigation devices and methods
US9031636B2 (en) 2012-07-19 2015-05-12 MRI Interventions, Inc. MRI-compatible head fixation apparatus
US9192446B2 (en) 2012-09-05 2015-11-24 MRI Interventions, Inc. Trajectory guide frame for MRI-guided surgeries
CN111621507A (zh) 2012-09-28 2020-09-04 北卡罗来纳-查佩尔山大学 靶向少突胶质细胞的aav载体
US20140243783A1 (en) 2012-10-06 2014-08-28 Raghu Raghavan Method of backflow reduction during material delivery through a needle into tissue
CA3123066A1 (en) 2012-12-18 2014-06-26 Alcyone Lifesciences, Inc. Systems and methods for reducing or preventing backflow in a delivery system
US9066966B2 (en) * 2013-02-01 2015-06-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
US9572928B2 (en) 2013-03-13 2017-02-21 MRI Interventions, Inc. Substance delivery devices, systems and methods
AU2014244167A1 (en) 2013-03-13 2015-10-08 The Children's Hospital Of Philadelphia Adeno-associated virus vectors and methods of use thereof
US9498575B2 (en) 2013-03-14 2016-11-22 MRI Interventions, Inc. Substance delivery devices, systems and methods
CA2904156C (en) * 2013-03-15 2023-01-10 The Children's Hospital Of Philadelphia Vectors comprising stuffer/filler polynucleotide sequences and methods of use
US20140277310A1 (en) 2013-03-15 2014-09-18 Medtronic Ardian Luxembourg S.a.r.I. Catheters Having Tethered Neuromodulation Units and Associated Devices, Systems, and Methods
US9618590B2 (en) 2013-03-15 2017-04-11 MRI Interventions, Inc. Tip assembly for MRI-compatible medical devices and MRI-compatible medical devices incorporating same
JP2016523835A (ja) * 2013-05-15 2016-08-12 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 中枢神経系へのアデノ随伴ウイルスを介した遺伝子導入
WO2014189794A1 (en) 2013-05-18 2014-11-27 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods
US10456533B2 (en) 2013-06-17 2019-10-29 Alcyone Lifesciences, Inc. Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters
JP6498670B2 (ja) 2013-07-31 2019-04-10 アルキオーネ・ライフサイエンシズ・インコーポレイテッドＡｌｃｙｏｎｅ Ｌｉｆｅｓｃｉｅｎｃｅｓ， Ｉｎｃ． 薬剤送達、治療、およびモニタリングのためのシステムおよび方法
WO2015057807A1 (en) 2013-10-16 2015-04-23 MRI Interventions, Inc. Surgical navigation systems, related devices and methods
WO2015113034A1 (en) 2014-01-27 2015-07-30 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods
WO2015113027A2 (en) 2014-01-27 2015-07-30 Medtronic Ardian Luxembourg S.A.R.L. Catheters with enhanced flexibility and associated devices, systems, and methods
US10595744B2 (en) 2014-02-14 2020-03-24 MRI Interventions, Inc. Surgical tool-positioning devices and related methods
EP3119306A2 (en) 2014-03-20 2017-01-25 Medtronic Ardian Luxembourg S.à.r.l. Neuromodulation catheters and related devices, systems, and methods
EP3151866B1 (en) 2014-06-09 2023-03-08 Voyager Therapeutics, Inc. Chimeric capsids
KR20170096998A (ko) * 2014-11-05 2017-08-25 보이저 테라퓨틱스, 인크. 파킨슨병의 치료를 위한 aadc 폴리뉴클레오티드
EP3273999A1 (en) * 2015-03-23 2018-01-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with friedreich ataxia
EP3286321A4 (en) * 2015-04-24 2018-10-17 University of Florida Research Foundation, Inc. Aav vector for treatment of friedreich's ataxia

Also Published As

Publication number Publication date
US20190365793A1 (en) 2019-12-05
EP3632923A1 (en) 2020-04-08
US20180021364A1 (en) 2018-01-25
AU2021204620A1 (en) 2021-07-29
MX2022003323A (es) 2022-04-18
HK1246815A1 (zh) 2018-09-14
EP3245221A4 (en) 2018-06-13
EP3245221A1 (en) 2017-11-22
WO2016115503A1 (en) 2016-07-21
CA2970730A1 (en) 2016-07-21
AU2016206478A1 (en) 2017-06-15

Similar Documents

Publication Publication Date Title
MX2022003323A (es) Polinucleotidos dirigidos al sistema nervioso central.
MX2018004755A (es) Entrega de polinucleotidos dirigidos al sistema nervioso central.
PH12019502793A1 (en) Aadc polynucleotides for the treatment of parkinson`s disease
MX2023010042A (es) Polinucleotidos moduladores.
MX2017005834A (es) Polinucleotidos aad para el tratamiento de la enfermedad de parkinson.
MX2023008693A (es) Polinucleotidos moduladores.
ZA202004100B (en) Diaryl macrocycles as modulators of protein kinases
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
PH12019502002A1 (en) Combination theraphy
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
MX2017011223A (es) Variantes de protoxina ii y metodos de uso.
MX2017006437A (es) Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor.
MX2017012654A (es) Variantes de protoxina-ii y metodos de uso.
MX2018004220A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
MX2018002446A (es) Compuestos heterociclicos fusionados como moduladores s1p.
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
EP3694558A4 (en) IL-4 FUSION FORMULATIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS
MX2017006513A (es) Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor.
MX2018004217A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
MX2017009608A (es) Compuestos anticancerigenos.
PH12018500682A1 (en) Oxa-diazaspiro compounds having activity against pain
PH12017501872A1 (en) Methods of treating diseases
MX2018000418A (es) Derivados de amida que tienen actividad multimodal contra el dolor.
TW201612183A (en) Diaryl macrocycles as modulators of protein kinases